Acute coronary syndrome associated with essential thrombocythemia

Journal of Cardiology

Volumn 54, Issue 3, 2009, Pages 485-489

  Kumagai, Naoko ^a   Mitsutake, Ryoko ^a   Miura, Shin ichiro ^a   Kawamura, Akira ^a   Takamiya, Yosuke ^a   Nishikawa, Hiroaki ^a   Uehara, Yoshinari ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndrome; Anti platelet drugs; Essential thrombocythemia; Hydroxyurea

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HYDROXYUREA; JANUS KINASE 2; WARFARIN;

ACUTE CORONARY SYNDROME; ADD ON THERAPY; ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BACKACHE; BARE METAL STENT; CASE REPORT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; FEMALE; FIBRINOLYTIC THERAPY; GENE MUTATION; HEART INFARCTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEDICAL EDUCATION; PAIN; PERCUTANEOUS CORONARY INTERVENTION; POINT MUTATION; SURGICAL EQUIPMENT; THORAX PAIN; THROMBOCYTHEMIA; THROMBOSIS PREVENTION; THROMBUS ASPIRATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYUREA; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STENTS; THROMBOCYTHEMIA, ESSENTIAL;

EID: 70450221709     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.03.001     Document Type: Article

References (20)

1. Rossi C., Randi M.L., Zerbinati P., Rinaldi V., and Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 244 (1998) 49-53
2. Tanaka S., Nishigaki K., Ojio S., Okubo M., Yasuda S., Ishihara Y., Kubota T., Takasugi N., Kawamura I., Yamaki T., Ushikoshi H., Aoyama T., Kawasaki M., Takemura G., and Minatoguchi S. Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?. J Cardiol 52 (2008) 39-48
3. Henriques J.P., Zijlstra F., Ottervanger J.P., de Boer M.J., van't Hof A.W., Hoorntje J.C., and Suryapranata H. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23 (2002) 1112-1127
4. Kralovics R., Passamonti F., Buser A.S., Teo S.S., Tiedt R., Passweg J.R., Tichelli A., Cazzola M., and Skoda R.C. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
5. Barbui T., Barosi G., Grossi A., Gugliotta L., Liberato L.N., Marchetti M., Mazzucconi M.G., Rodeghiero F., and Tura S. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 89 (2004) 215-232
6. Cortelazzo S., Viero P., Finazzi G., D'Emilio A., Rodeghiero F., and Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8 (1990) 556-562
7. Besses C., Cervantes F., Pereira A., Florensa L., Solé F., Hernández-Boluda J.C., Woessner S., Sans-Sabrafen J., Rozman C., and Montserrat E. Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia 13 (1999) 150-154
8. Tefferi A., Fonseca R., Pereira D.L., and Hoagland H.C. A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc 76 (2001) 22-28
9. Cortelazzo S., Finazzi G., Ruggeri M., Vestri O., Galli M., Rodeghiero F., and Barbui T. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 332 (1995) 1132-1136
10. De Stefano V., Za T., Rossi E., Vannucchi A.M., Ruggeri M., Elli E., Micò C., Tieghi A., Cacciola R.R., Santoro C., Gerli G., Vianelli N., Guglielmelli P., Pieri L., Scognamiglio F., et al. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica 93 (2008) 372-380
11. Landolfi R., and Di Gennaro L. Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica 93 (2008) 331-335
12. Cortelazzo S., Marchetti M., Orlando E., Falanga A., Barbui T., and Buchanan M.R. Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: role of the lipoxygenase pathway. Am J Hematol 57 (1998) 277-282
13. James C., Ugo V., Le Couédic J.P., Staerk J., Delhommeau F., Lacout C., Garçon L., Raslova H., Berger R., Bennaceur-Griscelli A., Villeval J.L., Constantinescu S.N., Casadevall N., and Vainchenker W. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144-1148
14. Campbell P.J., Scott L.M., Buck G., Wheatley K., East C.L., Marsden J.T., Duffy A., Boyd E.M., Bench A.J., Scott M.A., Vassiliou G.S., Milligan D.W., Smith S.R., Erber W.N., Bareford D., et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet 366 (2005) 1945-1953
15. Okayasu N., Murata M., Ueda A., Su K.M., Sada T., Ito T., Hasegawa Y., Matsumoto S., and Ito Y. Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary arteriogram. Jpn Heart J 22 (1981) 439-445
16. Saffitz J.E., Phillips E.R., Temesy-Armos P.N., and Roberts W.C. Thrombocytosis and fatal coronary heart disease. Am J Cardiol 52 (1983) 651-652
17. Douste-Blazy P., Taudou M.J., Delay M., Pris J., Sie P., Ribaut L., Galinier F., and Bernadet P. Essential thrombocythaemia and recurrent myocardial infarction. Lancet 2 (1984) 992
18. Kaya H., Gündogdu M., Tekin S.B., Akarsu E., and Bozkurt E. Essential thrombocythemia and recurrent myocardial infarction. Clin Lab Haematol 22 (2000) 161-162
19. Tekin M., Gökaslan S., Diker E., and Aydoǧdu S. Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera. Turk Kardiyol Dern Ars 36 (2008) 35-38
20. Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326 (1992) 242-250